Your browser doesn't support javascript.
loading
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery.
Rebollo-Lopez, María Jose; Lelièvre, Joël; Alvarez-Gomez, Daniel; Castro-Pichel, Julia; Martínez-Jiménez, Francisco; Papadatos, George; Kumar, Vinod; Colmenarejo, Gonzalo; Mugumbate, Grace; Hurle, Mark; Barroso, Vanessa; Young, Rob J; Martinez-Hoyos, María; González del Río, Rubén; Bates, Robert H; Lopez-Roman, Eva Maria; Mendoza-Losana, Alfonso; Brown, James R; Alvarez-Ruiz, Emilio; Marti-Renom, Marc A; Overington, John P; Cammack, Nicholas; Ballell, Lluís; Barros-Aguire, David.
Afiliação
  • Rebollo-Lopez MJ; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Lelièvre J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Alvarez-Gomez D; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Castro-Pichel J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Martínez-Jiménez F; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), Barcelona, Spain.
  • Papadatos G; Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain.
  • Kumar V; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.
  • Colmenarejo G; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
  • Mugumbate G; Centro de Investigación Básica, CSci Computational Chemistry, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Hurle M; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.
  • Barroso V; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
  • Young RJ; Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Martinez-Hoyos M; CSC Medicinal Chemistry, Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom.
  • González del Río R; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Bates RH; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Lopez-Roman EM; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Mendoza-Losana A; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Brown JR; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Alvarez-Ruiz E; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
  • Marti-Renom MA; Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Overington JP; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), Barcelona, Spain.
  • Cammack N; Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain.
  • Ballell L; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Barros-Aguire D; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.
PLoS One ; 10(12): e0142293, 2015.
Article em En | MEDLINE | ID: mdl-26642067
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha